Published Mar 13, 2023

Prof G Markets: Scott’s NJOY Stake, the JetBlue/Spirit Merger, and WeightWatchers Buys Ozempic Maker

Scott Galloway explores the intricacies of investment diversification through his NJOY experience, scrutinizes the JetBlue-Spirit merger amid antitrust challenges, and evaluates WeightWatchers' strategic shift into obesity treatment with its acquisition of an Ozempic maker, providing a comprehensive look at pivotal trends in finance, aviation, and health.
Episode Highlights
The Prof G Pod with Scott Galloway logo

Popular Clips

Episode Highlights

Related Episodes